Guardant Health 1 article

Guardant Health is a precision-oncology diagnostics company built around blood-based cancer testing and circulating-tumor-DNA analysis. Its scientific scope includes comprehensive genomic profiling, treatment-selection biomarkers, molecular residual disease and recurrence monitoring, together with research on earlier cancer detection. The organization should be distinguished from Guardant360 and other named assays: those are products, whereas Guardant Health is the company developing and operating the broader liquid-biopsy platform.

Diagnostics & Precision Medicine

October 9, 2026, 8:56 AM · 4 mins read

NCCN Pushes MRD Sensitivity to 10−6, Forcing Upheaval in Myeloma Testing

NCCN's new 10−6 sensitivity benchmark for minimal residual disease in multiple myeloma is shaking up diagnostics, driving labs to overhaul their molecular testing and sparking a scramble among industry players.